CN116287003A - 腓骨肌萎缩症小鼠模型及其构建方法与应用 - Google Patents
腓骨肌萎缩症小鼠模型及其构建方法与应用 Download PDFInfo
- Publication number
- CN116287003A CN116287003A CN202310176530.0A CN202310176530A CN116287003A CN 116287003 A CN116287003 A CN 116287003A CN 202310176530 A CN202310176530 A CN 202310176530A CN 116287003 A CN116287003 A CN 116287003A
- Authority
- CN
- China
- Prior art keywords
- gene
- fibula
- mouse model
- mouse
- site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010172 mouse model Methods 0.000 title claims abstract description 88
- 210000002082 fibula Anatomy 0.000 title claims abstract description 78
- 238000010276 construction Methods 0.000 title claims abstract description 17
- 206010002027 Amyotrophy Diseases 0.000 title claims abstract description 13
- 201000000585 muscular atrophy Diseases 0.000 claims abstract description 53
- 235000013601 eggs Nutrition 0.000 claims abstract description 50
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 46
- 201000006938 muscular dystrophy Diseases 0.000 claims abstract description 39
- 230000035772 mutation Effects 0.000 claims abstract description 37
- 238000004458 analytical method Methods 0.000 claims abstract description 25
- 206010064571 Gene mutation Diseases 0.000 claims abstract description 20
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 15
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 claims abstract description 13
- 238000010362 genome editing Methods 0.000 claims abstract description 13
- 238000012300 Sequence Analysis Methods 0.000 claims abstract description 12
- 210000004291 uterus Anatomy 0.000 claims abstract description 12
- 101150070004 E8 gene Proteins 0.000 claims abstract description 10
- 238000005516 engineering process Methods 0.000 claims abstract description 10
- 241000699670 Mus sp. Species 0.000 claims description 60
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 29
- 108020004414 DNA Proteins 0.000 claims description 21
- 108010058060 Alanine-tRNA ligase Proteins 0.000 claims description 13
- 102100037399 Alanine-tRNA ligase, cytoplasmic Human genes 0.000 claims description 13
- 238000011144 upstream manufacturing Methods 0.000 claims description 13
- 238000012408 PCR amplification Methods 0.000 claims description 12
- 238000012163 sequencing technique Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 108020005004 Guide RNA Proteins 0.000 claims description 10
- 229940088597 hormone Drugs 0.000 claims description 9
- 239000005556 hormone Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 101150067361 Aars1 gene Proteins 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 230000006801 homologous recombination Effects 0.000 claims description 4
- 238000002744 homologous recombination Methods 0.000 claims description 4
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 210000003101 oviduct Anatomy 0.000 claims description 4
- 102000002322 Egg Proteins Human genes 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 3
- 210000004681 ovum Anatomy 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 2
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 238000012257 pre-denaturation Methods 0.000 claims description 2
- 210000003414 extremity Anatomy 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 10
- 230000037444 atrophy Effects 0.000 abstract description 8
- 230000007170 pathology Effects 0.000 abstract description 8
- 206010003694 Atrophy Diseases 0.000 abstract description 7
- 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 12
- 230000003321 amplification Effects 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 210000003497 sciatic nerve Anatomy 0.000 description 8
- 210000003050 axon Anatomy 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000007830 nerve conduction Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 5
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 210000000715 neuromuscular junction Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101100479036 Mus musculus Aars1 gene Proteins 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 201000008987 Charcot-Marie-Tooth disease type 2B1 Diseases 0.000 description 3
- 102000006771 Gonadotropins Human genes 0.000 description 3
- 108010086677 Gonadotropins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000003210 demyelinating effect Effects 0.000 description 3
- 239000002622 gonadotropin Substances 0.000 description 3
- 210000000548 hind-foot Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 201000008919 Charcot-Marie-Tooth disease type 2B2 Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 101001003584 Homo sapiens Prelamin-A/C Proteins 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 208000021024 autosomal recessive inheritance Diseases 0.000 description 2
- 230000003376 axonal effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000001617 median nerve Anatomy 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 101150060211 AlaRS gene Proteins 0.000 description 1
- 201000008891 Charcot-Marie-Tooth disease type 4C Diseases 0.000 description 1
- 201000008888 Charcot-Marie-Tooth disease type 4D Diseases 0.000 description 1
- 201000009069 Charcot-Marie-Tooth disease type 4E Diseases 0.000 description 1
- 201000009061 Charcot-Marie-Tooth disease type 4F Diseases 0.000 description 1
- 206010062346 Congenital neuropathy Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 206010012305 Demyelination Diseases 0.000 description 1
- 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 1
- 101150059401 EGR2 gene Proteins 0.000 description 1
- 108010051748 Early Growth Response Protein 2 Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108700012776 GDAP Proteins 0.000 description 1
- 208000006411 Hereditary Sensory and Motor Neuropathy Diseases 0.000 description 1
- 241001454768 Mentzelia nuda Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 108700025784 N-myc downstream-regulated gene 1 Proteins 0.000 description 1
- 102000011324 NDRG Human genes 0.000 description 1
- 108050001500 NDRG Proteins 0.000 description 1
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 1
- 102100026531 Prelamin-A/C Human genes 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002638 denervation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000021995 hereditary motor and sensory neuropathy Diseases 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003007 myelin sheath Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007171 neuropathology Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001177 vas deferen Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Rheumatology (AREA)
- Animal Husbandry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310176530.0A CN116287003A (zh) | 2023-02-27 | 2023-02-27 | 腓骨肌萎缩症小鼠模型及其构建方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310176530.0A CN116287003A (zh) | 2023-02-27 | 2023-02-27 | 腓骨肌萎缩症小鼠模型及其构建方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116287003A true CN116287003A (zh) | 2023-06-23 |
Family
ID=86828096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310176530.0A Pending CN116287003A (zh) | 2023-02-27 | 2023-02-27 | 腓骨肌萎缩症小鼠模型及其构建方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116287003A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105821062A (zh) * | 2015-01-09 | 2016-08-03 | 深圳华大基因科技有限公司 | Amsh基因突变体及其应用 |
CN110438159A (zh) * | 2019-07-03 | 2019-11-12 | 广州中医药大学(广州中医药研究院) | 一种引发肌原纤维肌病的基因突变小鼠模型的构建方法 |
CN111424053A (zh) * | 2020-04-20 | 2020-07-17 | 福州大学 | 一种轴突型腓骨肌萎缩症果蝇模型的构建方法及应用 |
US20210393591A1 (en) * | 2018-10-26 | 2021-12-23 | The Jackson Laboratory | Treatments for charcot-marie-tooth disease |
-
2023
- 2023-02-27 CN CN202310176530.0A patent/CN116287003A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105821062A (zh) * | 2015-01-09 | 2016-08-03 | 深圳华大基因科技有限公司 | Amsh基因突变体及其应用 |
US20210393591A1 (en) * | 2018-10-26 | 2021-12-23 | The Jackson Laboratory | Treatments for charcot-marie-tooth disease |
CN110438159A (zh) * | 2019-07-03 | 2019-11-12 | 广州中医药大学(广州中医药研究院) | 一种引发肌原纤维肌病的基因突变小鼠模型的构建方法 |
CN111424053A (zh) * | 2020-04-20 | 2020-07-17 | 福州大学 | 一种轴突型腓骨肌萎缩症果蝇模型的构建方法及应用 |
Non-Patent Citations (1)
Title |
---|
CAI JL等,: "A stress-free strategy to correct point mutations in patient iPS cells", STEM CELL RES., vol. 53, pages 328 - 332 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shavit et al. | Impaired megakaryopoiesis and behavioral defects inmafG-null mutant mice | |
CN110951787B (zh) | 一种免疫缺陷小鼠、其制备方法及应用 | |
CN107815466A (zh) | 人源化基因改造动物模型的制备方法及应用 | |
CN109706184B (zh) | 自闭症模型犬的建立方法 | |
US20080289059A1 (en) | Methods for developing animal models | |
CN107815467A (zh) | 人源化基因改造动物模型的制备方法及应用 | |
EP2386564B1 (en) | Regulatable fusion promoters | |
CN109295104A (zh) | 一种Slco1b2基因敲除大鼠的构建方法及应用 | |
US10858669B2 (en) | Genetically modified chicken egg with an exogenous sequence knocked into the ovalbumin gene | |
CN108018310B (zh) | 可诱导的转基因小鼠心肌病动物模型的构建方法及应用 | |
US20220369608A1 (en) | Method for establishing diabetes disease model dog | |
CN116287003A (zh) | 腓骨肌萎缩症小鼠模型及其构建方法与应用 | |
CN116355963A (zh) | 一种cd24人源化小鼠模型的构建方法及其应用 | |
CN113491255B (zh) | 一种肥胖性ii型糖尿病斑马鱼模型的构建方法及应用 | |
CN112831522B (zh) | 一种条件性敲入人Siglec-6分子的小鼠模型及其构建方法 | |
CN113549637B (zh) | 一种小鼠phex基因snp位点及其应用 | |
CN114836476A (zh) | 一种FTO rs1421085 T>C点突变小鼠模型及其应用 | |
CN114763557A (zh) | Ddx5在抗病毒和调节免疫反应中的应用 | |
US20100005535A1 (en) | Compositions And Methods For Generating Transgenic Animals | |
CN112626122A (zh) | hKDR人源化小鼠模型及其建立方法和应用 | |
JP2000515386A (ja) | Ku欠損細胞と非ヒトトランスジェニック動物 | |
CN113699187B (zh) | 一种肠易激综合征小鼠模型及其应用 | |
CN113774128B (zh) | Gja8基因突变位点在制备诊断白内障疾病的制品中的应用 | |
CN115125273B (zh) | 一种乳头型颅咽管瘤动物模型的构建方法及应用 | |
CN118562880A (zh) | 一种构建多囊卵巢综合征疾病动物模型的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Sun Litao Inventor after: Zhang Jingjing Inventor after: Qin Qianni Inventor after: Zhou Jichang Inventor after: Zhou Zhongwei Inventor after: Li Shen Inventor after: Zhou Ying Inventor before: Sun Litao Inventor before: Zhou Jichang Inventor before: Zhou Zhongwei Inventor before: Zhang Jingjing Inventor before: Qin Qianni Inventor before: Li Shen Inventor before: Zhou Ying |
|
CB03 | Change of inventor or designer information |